Literature DB >> 23863231

Evaluating pain, sedation, and delirium in the neurologically critically ill-feasibility and reliability of standardized tools: a multi-institutional study.

Amy Yu1, Jeanne Teitelbaum, Jill Scott, Gail Gesin, Brittany Russell, Toan Huynh, Yoanna Skrobik.   

Abstract

OBJECTIVES: To assess the feasibility and reliability of systematic evaluations of analgesia, sedation level, and delirium features in the neurologically critically ill and to determine whether delirium features are linked to clinical outcomes in this population.
DESIGN: Multicentered prospective observational study.
SETTING: Neurological, Neurosurgical, Neurosciences or Surgical Trauma ICUs from three hospitals (two in Canada and one in the United States). PATIENTS: A convenience sample of adult NICU or neurologic, neurosurgical, neurosciences, or surgical trauma ICU patients admitted for greater than 12 hours from November 2011 to April 2012.
INTERVENTIONS: Systematic assessments were simultaneously and independently performed by a neurologist, intensivists, or trauma surgeon, and a nurse in three multispecialty ICUs. Pain was evaluated with the numeric rating scale or behavioral pain scale. Sedation was assessed using the Richmond Agitation-Sedation Scale. Patients with Richmond Agitation-Sedation Scale greater than or equal to -4 were screened for features of delirium with the Intensive Care Delirium Screening Checklist. Intraclass correlation coefficient was used to evaluate inter-rater reliability between the nurse and the physician for pain and sedation scales, and the kappa coefficient was calculated for concordance of the Intensive Care Delirium Screening Checklist items.
MEASUREMENTS AND MAIN RESULTS: 151 patients had 439 assessments. Pain and sedation were always assessable with excellent inter-rater reliability (numeric rating scale intraclass correlation coefficient, 0.92; behavior pain scale intraclass correlation coefficient, 0.83; and Richmond Agitation-Sedation Scale intraclass correlation coefficient, 0.92). Patients were sufficiently alert for delirium screening 3/4 of the time; Intensive Care Delirium Screening Checklist items had good concordance (kappa coefficients between 0.58 and 0.91 for the eight Intensive Care Delirium Screening Checklist items). Nonevaluable items were most often orientation, hallucinations, and speech or mood content. Furthermore, each additional Intensive Care Delirium Screening Checklist item present in proportion to the total evaluable Intensive Care Delirium Screening Checklist score was associated with a 10% increase in ICU length of stay.
CONCLUSIONS: Pain and sedation can be systematically assessed in the neurologically critically ill; the majority can also be screened for delirium features with excellent inter-rater reliability. Increased proportion of Intensive Care Delirium Screening Checklist items is associated with worse outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23863231     DOI: 10.1097/CCM.0b013e31828e96c0

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  2013: updates in delirium.

Authors:  Eduard E Vasilevskis; E Wesley Ely
Journal:  Neurohospitalist       Date:  2014-04

2.  A modified Sequential Organ Failure Assessment score using the Richmond Agitation-Sedation Scale in critically ill patients.

Authors:  Damien Viglino; Maxime Maignan; Guillaume Debaty
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

3.  Delirium Monitoring in Neurocritically Ill Patients: A Systematic Review.

Authors:  Mayur B Patel; Josef Bednarik; Patricia Lee; Yahya Shehabi; Jorge I Salluh; Arjen J Slooter; Kate E Klein; Yoanna Skrobik; Alessandro Morandi; Peter E Spronk; Andrew M Naidech; Brenda T Pun; Fernando A Bozza; Annachiara Marra; Sayona John; Pratik P Pandharipande; E Wesley Ely
Journal:  Crit Care Med       Date:  2018-11       Impact factor: 7.598

Review 4.  Pain measurement techniques: spotlight on mechanically ventilated patients.

Authors:  Isabela Freire Azevedo-Santos; Josimari Melo DeSantana
Journal:  J Pain Res       Date:  2018-11-21       Impact factor: 3.133

5.  Multi-modal Educational Curriculum to Improve Richmond Agitation-sedation Scale Inter-rater Reliability in Pediatric Patients.

Authors:  Margaret J Kihlstrom; Ashley P Edge; Kelly M Cherry; Paul J Zarick; Shawna D Beck; Jenny M Boyd
Journal:  Pediatr Qual Saf       Date:  2018-08-07

6.  A One-Day Prospective National Observational Study on Sedation-Analgesia of Patients with Brain Injury in French Intensive Care Units: The SEDA-BIP-ICU (Sedation-Analgesia in Brain Injury Patient in ICU) Study.

Authors:  Simon Poignant; Bernard Vigué; Patricia Balram; Mathieu Biais; Romain Carillon; Vincent Cottenceau; Claire Dahyot-Fizelier; Vincent Degos; Thomas Geeraerts; Patrick Jeanjean; Emmanuel Vega; Sigismond Lasocki; Fabien Espitalier; Marc Laffon
Journal:  Neurocrit Care       Date:  2021-07-30       Impact factor: 3.210

7.  First results about recovery of walking function in patients with intensive care unit-acquired muscle weakness from the General Weakness Syndrome Therapy (GymNAST) cohort study.

Authors:  Jan Mehrholz; Simone Mückel; Frank Oehmichen; Marcus Pohl
Journal:  BMJ Open       Date:  2015-12-23       Impact factor: 2.692

8.  Incidence, Risk Factors and Consequences of Emergence Agitation in Adult Patients after Elective Craniotomy for Brain Tumor: A Prospective Cohort Study.

Authors:  Lu Chen; Ming Xu; Gui-Yun Li; Wei-Xin Cai; Jian-Xin Zhou
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

9.  Use of Dexmedetomidine for Prophylactic Analgesia and Sedation in Patients With Delayed Extubation After Craniotomy: A Randomized Controlled Trial.

Authors:  Li-Hong Zhao; Zhong-Hua Shi; Guang-Qiang Chen; Ning-Ning Yin; Han Chen; Yuan Yuan; Wei Cao; Ming Xu; Jing-Jing Hao; Jian-Xin Zhou
Journal:  J Neurosurg Anesthesiol       Date:  2017-04       Impact factor: 3.956

10.  Health-related quality of life, participation, and physical and cognitive function of patients with intensive care unit-acquired muscle weakness 1 year after rehabilitation in Germany: the GymNAST cohort study.

Authors:  Simone Thomas; Jan Mehrholz
Journal:  BMJ Open       Date:  2018-07-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.